Conference sponsors 2021
Fujifilm is proud to return to Symposium Mammographicum as Platinum Sponsor for the second time and congratulates the organisation as it celebrates 40 years of supporting education, research and innovation in mammography.
We are delighted to welcome Dr Laurie Fajardo who will deliver the Fujifilm Symposium on the topic of Breast Density and Breast Cancer Risk Assessment – Will AI Add Value? Dr Fajardo is Professor of Radiology at the University of Utah, and has been involved in the development and evaluation of many new breast imaging technologies and therapies. She has delivered over 200 invited lectures and scientific papers nationally and internationally, and is the author of over 190 scientific papers. Don’t miss this important discussion on Monday 8 February at 3.45pm.
Delegates are also invited to attend the Fujifilm demonstration of the AMULET Innovality. This highly advanced mammography system can be configured for all clinical mammography applications, including:
- Dual-mode tomosynthesis – with options to suit every clinical scenario
- S-view using iterative reconstruction – so you can see every detail more clearly
- Contrast enhanced mammography – to expand your service
- Stereotactic and tomo-guided biopsy – with vertical and lateral approaches
- Breast density module – to support clinical decisions
- Intelligent AEC – to consistently optimise exposures, even for implants
The AMULET Innovality also offers design and technology which can significantly improve patient comfort. Features including the Fit Sweet compression paddle which wraps to individual breast shape, a fast workflow and ergonomic design all help to ensure the best mammography experience for both patient and mammographer.
At Endomag, we believe everyone deserves a better standard of cancer care. Many of the world’s leading physicians and hospitals use our technologies to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is.
At the heart of the company’s product platform is the Sentimag® localisation system. The Sentimag® system features a probe which works like a metal detector, and when placed near the skin’s surface is used to detect Endomag’s magnetic seed (Magseed®) or liquid tracer (Magtrace®), for tissue localisation and sentinel node biopsy procedures.
Contact us to find out more: www.endomag.com/contact
Siemens Healthineers is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. For more information and latest product line visit www.siemens-healthineers.co.uk.
LinkedIn: @Siemens Healthineers # SiemensHealthineers
Volpara Health is a purpose-driven software company on a mission to prevent advanced-stage breast cancer. The Volpara Breast Health Platform includes clinical decision support tools to enable radiologists to make informed and timely decisions about a patient’s need for supplemental imaging and/or genetic testing as part of personalized breast care. Each aspect of this platform is powered by Volpara Science — a set of clinically validated algorithms that use x-ray physics and artificial intelligence to assess breast tissue composition and imaging quality — to personalize patient care.
GE Healthcare is a leading global medical technology and digital solutions innovator. The company has a strong commitment to breast care, and has invested heavily into this technology over the past decades. It is about providing high quality imaging systems enabling clinicians to make faster, more informed decisions leading to positive clinical outcomes.
We all know someone who has been impacted by breast cancer, which is why our dedicated team work tirelessly to improve early detection and support a clear patient care pathway through innovative breast care solutions.
ScreenPoint Medical is the leading developer of AI driven image analysis technology which enables the automated reading of 2D and 2D mammograms. With proven accuracy matching that of experienced radiologists, ScreenPoint’s Transpara® system is the most advanced commercially available (CE marked and FDA cleared for 2D and 3D mammography), exploiting Big Data, Deep Learning and the latest advances in Artificial Intelligence to provide an evidence based multi-vendor solution. Transpara® is used in over 20 countries. We focus on helping to improve breast cancer survival rates by detecting cancer earlier so that treatment can be more effective and less invasive. www.screenpoint-medical.com